SK-UT-07 - Human Cancer - Myeloma Cell Line


Species: Human

Category: Cancer

Tissue of Origin: B Cell

Cancer Type: Myeloma


SK-UT-07 is a human B cell line.


This cell line was established from a B cell in a male with myeloma.

Lead Researcher/Research Laboratory

  • Lloyd J. Old, MD, former William E. Snee Chair in Cancer Immunology, MSK; former Director of the Ludwig Institute for Cancer Research

Key References

PubMed=6159646; DOI=10.1073/pnas.77.9.5429 Olsson L., Kaplan H.S. Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc. Natl. Acad. Sci. U.S.A. 77:5429-5431(1980)

Licensing Information

This cell line may be licensed nonexclusively for research or commercial purposes.

For internal research purposes by a commercial entity: Utilize MSK’s Express License, attached here. In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. Please note: This license is only available for select cell lines, including this one.

To proceed, please download this contract, fill in all relevant fields, and email a scanned version to Once this license has been executed by MSK, you will receive a signed copy and invoice, and can then place your order with ATCC.

For licensing requests for a commercial purpose:  Contact MSK’s Tangible Materials team at

For non-licensing requests from academic-research institutions: Contact Frances Weis-Garcia, PhD, Associate Laboratory Member/Head, Antibody & Bioresource Core Facility, MSK,

Stage of Development

Ready to use